Literature DB >> 18784435

Molecular profiling of isolated histological components of wilms tumor implicates a common role for the Wnt signaling pathway in kidney and tumor development.

Mariana Maschietto1, Beatriz de Camargo, Helena Brentani, Paul Grundy, Simone T Sredni, César Torres, Louise D Mota, Isabela W Cunha, Diogo F C Patrão, Cecília M L Costa, Fernando A Soares, Ricardo R Brentani, Dirce M Carraro.   

Abstract

Wilms tumor (WT), a tumor composed of three histological components - blastema (BL), epithelia and stroma - is considered an appropriate model system to study the biological relationship between differentiation and tumorigenesis. To investigate molecular associations between nephrogenesis and WT, the gene expression pattern of individual cellular components was analyzed, using a customized platform containing 4,608 genes. WT gene expression patterns were compared to genes regulated during kidney differentiation. BL had a closer gene expression pattern to the earliest stage of normal renal development. The BL gene expression pattern was compared to that of fetal kidney (FK) and also between FK and mature kidney, identifying 25 common deregulated genes supposedly involved in the earliest events of WT onset. Quantitative RT-PCR was performed, confirming the difference in expression levels for 13 of 16 genes (81.2%) in the initial set and 8 of 13 (61.5%) in an independent set of samples. An overrepresentation of genes belonging to the Wnt signaling pathway was identified, namely PLCG2, ROCK2 and adenomatous polyposis coli (APC). Activation of the Wnt pathway was confirmed in WT, using APC at protein level and PLCG2 at mRNA and protein level. APC showed positive nuclear immunostaining for an independent set of WT samples, similarly to the FK in week 11. Lack of PLCG2 expression was confirmed in WT and in FK until week 18. Taken together, these results provided molecular evidence of the recapitulation of the embryonic kidney by WT as well as involvement of the Wnt pathway in the earliest events of WT onset. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784435     DOI: 10.1159/000155210

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  12 in total

1.  Early gene expression changes in skeletal muscle from SOD1(G93A) amyotrophic lateral sclerosis animal model.

Authors:  Gabriela P de Oliveira; Jessica R Maximino; Mariana Maschietto; Edmar Zanoteli; Renato D Puga; Leandro Lima; Dirce M Carraro; Gerson Chadi
Journal:  Cell Mol Neurobiol       Date:  2014-01-18       Impact factor: 5.046

2.  Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.

Authors:  Dinesh Kumar Sahu; Neetu Singh; Mumani Das; Jiledar Rawat; Devendra Kumar Gupta
Journal:  Pediatr Surg Int       Date:  2022-09-15       Impact factor: 2.003

3.  Epigenetic silencing of CRABP2 and MX1 in head and neck tumors.

Authors:  Marilia F Calmon; Rodrigo V Rodrigues; Carla M Kaneto; Ricardo P Moura; Sabrina D Silva; Louise Danielle C Mota; Daniel G Pinheiro; Cesar Torres; Alex F de Carvalho; Patrícia M Cury; Fabio D Nunes; Ines Nobuko Nishimoto; Fernando A Soares; Adriana M A da Silva; Luis P Kowalski; Helena Brentani; Cleslei F Zanelli; Wilson A Silva; Paula Rahal; Eloiza H Tajara; Dirce M Carraro; Anamaria A Camargo; Sandro R Valentini
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

4.  Influence of the interaction between nodal fibroblast and breast cancer cells on gene expression.

Authors:  Rosângela Portilho Costa Santos; Ticiana Thomazine Benvenuti; Suzana Terumi Honda; Paulo Roberto Del Valle; Maria Lucia Hirata Katayama; Helena Paula Brentani; Dirce Maria Carraro; Patrícia Bortman Rozenchan; Maria Mitzi Brentani; Eduardo Carneiro de Lyra; César Henrique Torres; Marcia Batista Salzgeber; Jane Haruko Lima Kaiano; João Carlos Sampaio Góes; Maria Aparecida Azevedo Koike Folgueira
Journal:  Tumour Biol       Date:  2010-09-06

5.  Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset.

Authors:  M Maschietto; A P Trapé; F S Piccoli; T I Ricca; A A M Dias; R A Coudry; P A Galante; C Torres; L Fahhan; S Lourenço; P E Grundy; B de Camargo; S de Souza; E J Neves; F A Soares; H Brentani; D M Carraro
Journal:  Cell Death Dis       Date:  2011-11-03       Impact factor: 8.469

6.  Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour.

Authors:  Giovana T Torrezan; Elisa N Ferreira; Adriana M Nakahata; Bruna D F Barros; Mayra T M Castro; Bruna R Correa; Ana C V Krepischi; Eloisa H R Olivieri; Isabela W Cunha; Uri Tabori; Paul E Grundy; Cecilia M L Costa; Beatriz de Camargo; Pedro A F Galante; Dirce M Carraro
Journal:  Nat Commun       Date:  2014-06-09       Impact factor: 14.919

7.  The IGF signalling pathway in Wilms tumours--a report from the ENCCA Renal Tumours Biology-driven drug development workshop.

Authors:  Mariana Maschietto; Jocelyn Charlton; Daniela Perotti; Paolo Radice; James I Geller; Kathy Pritchard-Jones; Mark Weeks
Journal:  Oncotarget       Date:  2014-09-30

8.  Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors.

Authors:  A C V Krepischi; M Maschietto; E N Ferreira; A G Silva; S S Costa; I W da Cunha; B D F Barros; P E Grundy; C Rosenberg; D M Carraro
Journal:  Mol Cytogenet       Date:  2016-02-24       Impact factor: 2.009

9.  Frizzled-7 promoter is highly active in tumors and promoter-driven Shiga-like toxin I inhibits hepatocellular carcinoma growth.

Authors:  Hongpan Xu; Lailing Gong; Yanyan Xia; Lili Qu; Qiwen Li; Lu Pang; Jin Si; Zhiyang Li
Journal:  Oncotarget       Date:  2015-11-24

10.  HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients.

Authors:  Lourdes Hontecillas-Prieto; Daniel J García-Domínguez; Rosa García-Mejías; Gema L Ramírez-Villar; Carmen Sáez; Enrique de Álava
Journal:  Oncotarget       Date:  2017-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.